ELIZABETH M. SCHMALZ SHAHEEN

Corporate Board Profile

Tech Score: 0/100

APPLIED DNA SCIENCES INC

Filing Date	Source Excerpt
2023-08-08	Ms. Elizabeth M. Schmalz Shaheen has been a member of the Board of Directors since June 1, 2017. ... Ms. Schmalz Shaheen’s track record of accomplishments as a strategist and products leader within the cosmetics and personal care industries led the Board of Directors to conclude she should serve as a director of the Company. ... Compensation Committee Messrs. Bitzer, Ceccoli and Shamash (Chairperson) and Ms. Schmalz Shaheen served on the compensation committee ... Nominating Committee Messrs. Shamash (Chairperson), Bitzer and Simon and Ms. Schmalz Shaheen served on the nominating committee.
2024-08-21	Ms. Elizabeth M. Schmalz Shaheen has been a member of the Board of Directors since June 1, 2017. She has served as President of American Flavors & Fragrances LLC. None of the members of our Board of Directors received any other compensation in respect of fiscal 2023. In fiscal 2023, on January 25, 2023, we granted an Option to purchase 5,632 shares of our Common Stock (having a grant date fair value of $150,000) to each of our non-employee directors, in respect of fiscal year 2023.

Filing Date

Source Excerpt

2023-08-08

Ms. Elizabeth M. Schmalz Shaheen has been a member of the Board of Directors since June 1, 2017. ... Ms. Schmalz Shaheen’s track record of accomplishments as a strategist and products leader within the cosmetics and personal care industries led the Board of Directors to conclude she should serve as a director of the Company. ... Compensation Committee Messrs. Bitzer, Ceccoli and Shamash (Chairperson) and Ms. Schmalz Shaheen served on the compensation committee ... Nominating Committee Messrs. Shamash (Chairperson), Bitzer and Simon and Ms. Schmalz Shaheen served on the nominating committee.

2024-08-21

Ms. Elizabeth M. Schmalz Shaheen has been a member of the Board of Directors since June 1, 2017. She has served as President of American Flavors & Fragrances LLC. None of the members of our Board of Directors received any other compensation in respect of fiscal 2023. In fiscal 2023, on January 25, 2023, we granted an Option to purchase 5,632 shares of our Common Stock (having a grant date fair value of $150,000) to each of our non-employee directors, in respect of fiscal year 2023.

Data sourced from SEC filings. Last updated: 2025-10-11